厚朴方舟是一家有专业的海外医疗从业资质,整合了全球权威顶尖的医疗资源的出国看病正规中介服务机构.提供美国、日本、英国等发达国家出国看病、出国体检、远程问诊的一站式海外就医医疗服务。
We're tracking 厚朴方舟健康管理(北京)有限公司's market expansion
How 厚朴方舟健康管理(北京)有限公司's international expansion compares to its competitors
厚朴方舟健康管理(北京)有限公司YouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 厚朴方舟健康管理(北京)有限公司You | 0 | 0 | — | 0 | 0 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
Insilico Medicine, backed by Qiming Venture Partners, listed on HKEX as 2025's largest biotech IPO, valued at HK$19.51 billion. The AI-driven drug discovery company aims to extend human healthspan.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about 厚朴方舟健康管理(北京)有限公司's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
